首頁
倫理決策輔助
哲學/宗教
0
0
基於功利主義與義務論框架，分析商業場景中的道德兩難，提供合規且具人文關懷的決策建議。
提示內容
複製
複製
Act as a senior corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company developing a life-saving drug faces a dilemma regarding whether to partially release clinical trial data to accelerate approval, potentially sacrificing some subjects' privacy for greater public health benefits. Combine the utilitarian principle of maximizing happiness with the deontological respect for individual rights to evaluate the ethical risks of this decision. Provide a balanced solution that considers legal compliance, social responsibility, and long-term brand reputation, avoiding simple binary judgments, and focus on how to balance procedural justice with outcome justice.
複製
請扮演資深企業倫理顧問，針對以下具體商業場景進行分析：一家製藥公司在研發救命藥物時，面臨是否將臨床試驗數據部分公開以加速審批，從而可能犧牲部分受試者隱私以換取更大公眾健康利益的困境。請結合功利主義的最大幸福原則與義務論對個體權利的尊重，評估該決策的倫理風險，並給出一個兼顧法律合規、社會責任感及長期品牌聲譽的平衡方案，避免簡單的二元對立判斷，重點闡述如何在程序正義與結果正義之間取得平衡。
複製
評論 (0)
0/300
推薦
倫理決策輔助
Act as a corporate ethics consultant to evaluate the following business scenario: A pharmaceutical company discovers its best-selling drug has minor but negligible side effects with long-term use, yet concealing this information would cause a stock crash and impact employee benefits. Analyze the moral risks of concealment using both utilitarian consequentialism and Kantian deontology, weigh shareholder interests against patient safety, and provide a decision recommendation that balances compliance with corporate social responsibility, ensuring logical consistency and adherence to business ethical standards.
倫理決策輔助
Please conduct an ethical analysis for the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has a minor but foreseeable side effect with long-term use, increasing cardiovascular risk for patients, but discontinuing the drug would cause病情 worsening for some dependent patients. Please evaluate whether the company should proactively recall the drug and disclose side effects, combining the utilitarian principle of maximizing happiness for the greatest number with the deontological requirement of respecting patient autonomy and informed consent. Weigh the short-term financial loss against long-term brand trust and legal liability from the perspectives of stakeholders (patients, shareholders, employees, public), and finally provide a specific action recommendation that balances moral responsibility and corporate sustainability, explaining how this recommendation balances the interests of all parties.
倫理決策輔助
Act as a senior corporate ethics consultant to conduct a moral deduction for the following specific business scenario: A pharmaceutical company discovers during clinical trials that a drug has minor but long-term neurological side effects, yet it significantly extends the survival of late-stage cancer patients with no alternative therapies. Please analyze how the company should balance shareholder interests, patient health rights, and social responsibility by combining the utilitarian principle of maximizing happiness with the deontological perspective of respecting patient autonomy and the duty of non-maleficence, specifically regarding whether informed consent forms should explicitly mention these side effects, and provide specific communication strategies and ethical decision-making advice ensuring rigorous logic and compliance with modern business ethics standards.
倫理決策輔助
Please analyze the following specific ethical dilemma encountered in business operations: A pharmaceutical company discovers that its best-selling drug has mild but predictable side effects with long-term use, affecting the quality of life for some elderly patients, but discontinuing the drug would lead to more severe health risks. Please evaluate the moral rationality of three options—continuing sales, modifying label warnings, or initiating a recall—by combining the utilitarian principle of maximizing happiness with the deontological requirement of respecting patient autonomy, and provide a balanced recommendation that considers both corporate responsibility and patient well-being, ensuring the analysis is logically rigorous and compliant with business ethics standards.
倫理決策輔助
Act as a senior corporate ethics consultant to conduct a moral deduction for the following specific business scenario: A pharmaceutical company developing a life-saving new drug faces a situation where clinical trial data is partially missing, yet market demand is urgent. Please analyze the ethical consequences of continuing or pausing the trial by combining utilitarian considerations for the greatest good of the majority with deontological requirements for procedural justice, and provide specific action recommendations that balance legal compliance, social trust, and long-term business sustainability, ensuring the decision-making process is transparent and adheres to the highest industry ethical standards.
倫理決策輔助
Act as a corporate ethics consultant to conduct a deep moral analysis of the following specific business scenario: A pharmaceutical company discovers that its marketed drug has minor but non-fatal side effects with long-term use, yet withdrawing the product would cause the company to go bankrupt and affect thousands of patients relying on it. Please evaluate the moral weight of three options—withdrawal, continued sales with enhanced warnings, or voluntary recall with compensation—by integrating both utilitarian (maximizing overall well-being) and deontological (respecting patient autonomy and informed consent) ethical frameworks. Finally, provide a balanced decision recommendation that considers legal compliance, corporate survival, and patient rights, explaining its ethical justification.
